Skip to content

Clinical trials

Phase 3 Hypersensitivity trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Phase: Phase 3 Country / region: France Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20082
20101
20173
20182
20211
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated2
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aimmune Therapeutics, Inc.3
Sodilac2
Stallergenes Greer2
ALK-Abelló A/S1
Artu Biologicals1
AstraZeneca1
DBV Technologies1
Novartis Pharmaceuticals1
University Hospital, Rouen1
University Hospital, Strasbourg, France1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity14
Peanut Hypersensitivity4
Asthma2
Bronchial Diseases2
Immune System Diseases2
Lung Diseases2
Lung Diseases, Obstructive2
Respiratory Tract Diseases2
Conjunctivitis, Allergic1
Drug Hypersensitivity1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.